Eloxx Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$3.59M, a 52.2% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$20.5M, a 51% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.1M, a 46% increase from 2021.
  • Eloxx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$66.7M, a 93% decline from 2020.
  • Eloxx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$34.6M, a 32% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$20.5M -$3.59M +$3.92M +52.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$24.4M -$4.34M +$6.28M +59.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-13
Q1 2023 -$30.7M -$6.23M +$5.39M +46.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-13
Q4 2022 -$36.1M -$6.32M +$5.77M +47.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$41.8M -$7.51M +$2.38M +24% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$44.2M -$10.6M +$25.4M +70.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$69.7M -$11.6M -$2.93M -33.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$66.7M -$12.1M -$5.96M -97.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$60.8M -$9.89M -$3.27M -49.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$57.5M -$36.1M -$28.2M -357% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$29.3M -$8.69M +$5.25M +37.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$34.6M -$6.13M +$5.51M +47.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$40.1M -$6.62M +$6.26M +48.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$46.3M -$7.89M +$6.56M +45.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$52.9M -$13.9M -$2.03M -17% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$50.9M -$11.6M +$2.39M +17.1% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-30
Q3 2019 -$53.3M -$12.9M -$1.71M -15.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$51.6M -$14.4M -$1.04M -7.78% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 -$50.5M -$11.9M -$3.33M -38.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 -$47.2M -$14M -$3.43M -32.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-12
Q3 2018 -$43.8M -$11.2M -$7.12M -176% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$36.6M -$13.4M -$9.53M -246% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-06
Q1 2018 -$27.1M -$8.59M -$5.91M -221% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-06
Q4 2017 -$21.2M -$10.6M -$9.81M -1242% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-16
Q3 2017 -$11.4M -$4.04M -$3.11M -333% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$8.28M -$3.88M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$2.68M +$401K +13% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$790K +$3.07M +79.5% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-10
Q3 2016 -$934K -$753K -417% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q1 2016 -$3.08M -$1.85M -151% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 -$3.86M +$6.89M +64.1% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 -$181K +$5M +96.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q1 2015 -$20.8M -$1.23M +$920K +42.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$21.8M -$10.7M -$9.13M -563% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 -$12.6M -$5.18M -$3.4M -191% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$9.23M -$3.67M -$1.74M -90.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-10-13
Q1 2014 -$7.48M -$2.15M -$1.31M -157% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$6.17M -$1.62M -$350K -27.5% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$5.82M -$1.78M +$301K +14.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$6.12M -$1.93M -$492K -34.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-10-09
Q1 2013 -$5.63M -$837K +$224K +21.1% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$5.85M -$1.27M +$258K +16.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$6.11M -$2.09M -$1.05M -101% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$5.07M -$1.44M +$1.27M +46.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-09-29
Q1 2012 -$6.34M -$1.06M +$344K +24.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$6.68M -$1.53M -$391K -34.4% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 -$6.29M -$1.04M +$976K +48.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$7.27M -$2.71M Apr 1, 2011 Jun 30, 2011 10-K 2013-09-11
Q1 2011 -$1.41M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q4 2010 -$1.14M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$2.02M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.